Tekla World Healthcare Fund sets up up to $150 million at-the-market share sale
The fund entered a distribution agreement dated December 14, 2022, with Foreside Fund Services, allowing it to sell common shares worth up to $150 million at market prices over time. Foreside has also engaged UBS Securities as a sub-placement agent for these sales. The filing does not report any shares sold yet, but future sales could add shares outstanding and raise capital for the fund.
Key points
- Up to $150 million of common shares may be offered through Foreside Fund Services as agent, from time to time.
- The fund pays Foreside a 1.00% commission on gross sale proceeds; Foreside pays UBS up to 0.80% of those proceeds.
- Agreements are dated December 14, 2022, under a prospectus supplement and a shelf registration on Form N-2 (File No. 333-267555).
- The fund may not sell shares below current net asset value, excluding distributing commissions or discounts.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 19, 2022.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.